Dr. Ali Salavati, MD, MPH

Dr. Salavati practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Salavati's NPI, 1669868857, was assigned on April 14, 2015. Dr. Salavati graduated from Tehran University of Medical Sciences School of Medicine in 2010. Dr. Salavati holds California license A181116.

Dr. Salavati's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Salavati's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Salavati is also affiliated with The Johns Hopkins Hospital. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Salavati to 2 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salavati practices, 7 sites in all. Vendor and product names are available with a free account.

Nuclear medicine is Dr. Salavati's primary specialty in the NPI Registry, under taxonomy code 207U00000X. Dr. Salavati is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dmand AI has Dr. Salavati's licenses on file in 3 states: California, Maryland and Minnesota.

CMS data shows 795 Medicare services from Dr. Salavati across 7 procedure codes in 2024, for 735 Medicare patients. Medicare paid $114,439 for them.

CMS counts 735 Medicare patients who saw Dr. Salavati in 2024. The largest group is 65 to 74, with 340 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salavati's median patient age at 63, with 57% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Salavati for performance year 2024, reported as part of a group. Dr. Salavati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salavati as offering telehealth.

Dmand AI links 76 papers to Dr. Salavati, published from 2006 to 2024. 2014 was the busiest year, with 7. The most frequent topics are Fluorodeoxyglucose F18, Positron-Emission Tomography and Tomography, X-Ray Computed. Dr. Salavati has published most often in Eur J Nucl Med Mol Imaging. Dr. Salavati's most frequent co-authors are Abass Alavi, MD, Martin Gilbert Pomper, MD, PhD and Jerry Walter Froelich, MD.

Dr. Salavati graduated from Tehran University of Medical Sciences School of Medicine in 2010.

Dr. Salavati is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.